Agilon Health (NYSE:AGL) Shares Break Above 50 Day Moving Average – What’s Next?

Posted by Stanley Muller on Nov 4th, 2026

Agilon Health, Inc. (NYSE:AGL – Get Free Report)’s stock price passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $87.43 and traded as high as $91.11. Agilon Health shares last traded at $87.5340, with a volume of 329,712 shares trading hands.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on AGL shares. Robert W. Baird set a $116.00 price objective on shares of Agilon Health in a research note on Thursday, August 6th. Truist Financial set a $112.00 target price on Agilon Health and gave the company a “hold” rating in a report on Thursday, August 6th. Royal Bank Of Canada set a $125.00 price target on Agilon Health in a report on Tuesday, September 15th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research note on Monday, August 24th. Finally, JPMorgan Chase & Co. upped their price target on Agilon Health from $31.00 to $85.00 and gave the stock an “underweight” rating in a research note on Monday, August 24th. Six equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Agilon Health currently has a consensus rating of “Hold” and an average target price of $102.25.

Check Out Our Latest Research Report on AGL

Agilon Health Stock Up 1.0%

The stock’s fifty day moving average is $87.43 and its two-hundred day moving average is $65.50. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $1.47 billion, a PE ratio of -6.13 and a beta of 3.10.

Agilon Health (NYSE:AGL – Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The company had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.45 billion. As a group, analysts predict that Agilon Health, Inc. will post -2.90 EPS for the current year.

Hedge Funds Weigh In On Agilon Health

Large investors have recently made changes to their positions in the stock. Sterling Capital Management LLC purchased a new position in Agilon Health during the 3rd quarter valued at about $33,000. Root Financial Partners LLC purchased a new stake in shares of Agilon Health in the third quarter worth about $57,000. State of Alaska Department of Revenue purchased a new stake in shares of Agilon Health in the third quarter worth about $64,000. Allworth Financial LP bought a new position in shares of Agilon Health in the second quarter valued at approximately $114,000. Finally, Proficio Capital Partners LLC bought a new position in shares of Agilon Health in the second quarter valued at approximately $210,000.

About Agilon Health

(Get Free Report)

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company works with physician practices serving primarily older adults enrolled in Medicare Advantage and helps them manage the cost, quality and coordination of care for their patient populations.

Agilon provides a technology-enabled platform that includes population health analytics, clinical and administrative support, care coordination resources and practice-management capabilities.